Abstract
BackgroundThe Anti Tumour Necrosis Factor (aTNF) therapy in Rheumatics Diseases (RD) had changed the prognosis of theses conditions in the last decade. Unfortunately, aTNF therapy is associated a high-risk rate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have